Rocket Pharmaceuticals (NASDAQ: RCKT) has announced significant leadership changes in its finance department. John Militello, VP of Finance and Principal Accounting Officer, has resigned, with his departure effective July 7, 2026. Joseph Manhede, who joined the company in April 2026 as Associate Vice President, Corporate Controller, will assume the role of Principal Accounting Officer starting July 8, 2026, with no new compensatory arrangements.

Jack Henry & Associates (NASDAQ: JKHY) has received a consensus "Moderate Buy" rating from 14 brokerages, with an average 1-year price target of $187.31. The company recently reported strong quarterly results, beating EPS expectations and showing an 8.7% revenue increase. Insider buying by CEO Gregory R. Adelson and CFO Mimi Carsley, alongside significant institutional ownership, highlights confidence in the technology solutions provider.

This article provides the latest SEC filings information and comprehensive financial data for Dexcom Inc (DXCM). It details the company's recent stock performance, key financial metrics such as market cap, income, sales, P/E ratio, and growth rates. The information also includes insider and institutional ownership, profitability margins, and analyst recommendations.

Alley Investment Management Company LLC significantly increased its holdings in RTX Corporation by 1,440.3% in the first quarter, bringing its total stake to 26,802 shares valued at $5.17 million. This increase comes amidst favorable news for RTX, including a $1.10 billion U.S. Navy missile contract and its F119 engine surpassing one million flight hours, bolstering its defense portfolio and demonstrating operational strength. Analysts maintain a "Moderate Buy" rating with an average price target of $211.38, and the company continues to return value to shareholders with a quarterly dividend of $0.73 per share.

Interactive Strength Inc. (TRNR) has implemented a 1-for-7 reverse stock split, effective June 29, 2026, to reduce its outstanding shares from 3.6 million to approximately 0.5 million. This action is intended to help the company regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share. Trading on a split-adjusted basis began on June 30, 2026, with no change to stockholder ownership percentages or voting rights, and fractional shares will be paid in cash.

Sue Ann R. Hamilton has resigned from the Board of Universal Electronics (UEIC) and its committees, effective June 30, 2026. The company stated that her resignation was not due to any disputes or disagreements with management or the Board. The details of her replacement and specific committee role changes were not disclosed.

This article displays the forward Enterprise Value to EBITDA for 2U, Inc. (MUN:2U10). It indicates that the market was closed at the time of viewing and no trades were made. The page provides a financial overview for the company.

This article provides a financial overview for Vocodia Holdings Corp. (OTC:VHAI), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed with no trades at the time of publication. The content also notes key data providers for financial information.

Vericel Corp's Chief Medical Officer, Jonathan Mark Hopper, executed a pre-scheduled transaction on June 26, 2026, exercising options for 10,000 shares at $29.82 each and simultaneously selling those 10,000 shares on the open market for $45.00 per share. These sales were conducted under a Rule 10b5-1 trading plan adopted in May 2025. Following the transaction, Hopper retains 75,753 direct shares and 25,000 stock options, demonstrating continued equity exposure to the company.

This article from Investing.com reports on a Form 4 filing for Vericel Corp Ord for the period ending June 30. It provides the news without further details, alongside various market data and other news headlines. The Form 4 filing is a standard SEC document indicating changes in beneficial ownership of a company's securities by its directors, officers, or significant shareholders.